Chemical Compound Review:
ALLYLAMINE prop-2-en-1-amine
Synonyms:
Monoallylamine, Polyallylamine, PAA-L, allyl-amine, PubChem19133, ...
- Ultrastructural alterations in allylamine cardiovascular toxicity. Late myocardial and vascular lesions. Boor, P.J., Ferrans, V.J. Am. J. Pathol. (1985)
- Use of terbinafine in mouse and rat models of Pneumocystis carinii pneumonia. Walzer, P.D., Ashbaugh, A. Antimicrob. Agents Chemother. (2002)
- Synthesis and antifungal activity of (E)-N-(6,6-dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphtha lenemethanamine (SF 86-327) and related allylamine derivatives with enhanced oral activity. Stütz, A., Petranyi, G. J. Med. Chem. (1984)
- Ultrastructural alterations in allylamine- induced cardiomyopathy: early lesions. Boor, P.J., Ferrans, V.J. Lab. Invest. (1982)
- Novel genomic targets in oxidant-induced vascular injury. Partridge, C.R., Williams, E.S., Barhoumi, R., Tadesse, M.G., Johnson, C.D., Lu, K.P., Meininger, G.A., Wilson, E., Ramos, K.S. J. Mol. Cell. Cardiol. (2005)
- Redox regulation of c-Ha-ras and osteopontin signaling in vascular smooth muscle cells: implications in chemical atherogenesis. Ramos, K.S. Annu. Rev. Pharmacol. Toxicol. (1999)
- A role for a new vascular enzyme in the metabolism of xenobiotic amines. Boor, P.J., Hysmith, R.M., Sanduja, R. Circ. Res. (1990)
- Molecular cloning and expression of rat squalene epoxidase. Sakakibara, J., Watanabe, R., Kanai, Y., Ono, T. J. Biol. Chem. (1995)
- Inactivation of monoamine oxidase by allylamine does not result in flavin attachment. Silverman, R.B., Hiebert, C.K., Vazquez, M.L. J. Biol. Chem. (1985)
- Overview of topical therapy for common superficial fungal infections and the role of new topical agents. Brennan, B., Leyden, J.J. J. Am. Acad. Dermatol. (1997)
- Ethanol ingestion on allylamine-induced experimental subendocardial fibrosis. Kato, K., Nakazawa, M., Masani, F., Izumi, T., Shibata, A., Imai, S. Alcohol (1995)
- Myocardial mechanics in allylamine-induced myocardial fibrosis. Nakamura, Y., Wiegner, A.W., Aslanis, J.T., Apstein, C.S., Bing, O.H. Am. J. Physiol. (1986)
- Altered protein secretion and extracellular matrix deposition is associated with the proliferative phenotype induced by allylamine in aortic smooth muscle cells. Ramos, K.S., Weber, T.J., Liau, G. Biochem. J. (1993)
- Synthesis and structure-activity relationships of naftifine-related allylamine antimycotics. Stütz, A., Georgopoulos, A., Granitzer, W., Petranyi, G., Berney, D. J. Med. Chem. (1986)
- Regulation of alpha7-integrin expression in vascular smooth muscle by injury-induced atherosclerosis. Chao, J.T., Meininger, G.A., Patterson, J.L., Jones, S.A., Partridge, C.R., Neiger, J.D., Williams, E.S., Kaufman, S.J., Ramos, K.S., Wilson, E. Am. J. Physiol. Heart Circ. Physiol. (2004)
- Biotransformation of the cardiovascular toxin, allylamine, by rat and human cardiovascular tissue. Boor, P.J., Nelson, T.J. J. Mol. Cell. Cardiol. (1982)
- Allylamine cardiotoxicity--IV. Metabolism to acrolein by cardiovascular tissues. Nelson, T.J., Boor, P.J. Biochem. Pharmacol. (1982)
- Cell growth on immobilized cell-growth factor. 10. Insulin and polyallylamine co-immobilized materials. Zheng, J., Ito, Y., Imanishi, Y. Biomaterials (1994)
- Activity of terbinafine in experimental fungal infections of laboratory animals. Petranyi, G., Meingassner, J.G., Mieth, H. Antimicrob. Agents Chemother. (1987)
- Design, characterization, and one-point in vivo calibration of a subcutaneously implanted glucose electrode. Csöregi, E., Quinn, C.P., Schmidtke, D.W., Lindquist, S.E., Pishko, M.V., Ye, L., Katakis, I., Hubbell, J.A., Heller, A. Anal. Chem. (1994)
- Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albicans. Ryder, N.S., Seidl, G., Troke, P.F. Antimicrob. Agents Chemother. (1984)
- Rapid access to tetracyclic ring system of lennoxamine type natural product by combined use of a novel three-component reaction and Pummerer cyclization. Gámez Montaño, R., Zhu, J. Chem. Commun. (Camb.) (2002)
- Lipid modified polyelectrolyte microcapsules with controlled diffusion. Krishna, G., Shutava, T., Lvov, Y. Chem. Commun. (Camb.) (2005)
- Cloning and expression of squalene epoxidase from the pathogenic yeast Candida albicans. Favre, B., Ryder, N.S. Gene (1997)
- Modulation of cyclin dependent kinase inhibitor proteins and ERK1/2 activity in allylamine-injured vascular smooth muscle cells. Jones, S.A., Patterson, J.L., Chao, J.T., Ramos, K.S., Wilson, E. J. Cell. Biochem. (2004)
- Donnan permselectivity in layer-by-layer self-assembled redox polyelectrolye thin films. Calvo, E.J., Wolosiuk, A. J. Am. Chem. Soc. (2002)
- Structural regulation of a peptide-conjugated graft copolymer: a simple model for amyloid formation. Koga, T., Taguchi, K., Kobuke, Y., Kinoshita, T., Higuchi, M. Chemistry (Weinheim an der Bergstrasse, Germany) (2003)
- Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycoses. Monk, J.P., Brogden, R.N. Drugs (1991)
- Radio frequency plasma polymer coatings for affinity capture MALDI mass spectrometry. Li, M., Timmons, R.B., Kinsel, G.R. Anal. Chem. (2005)
- Bioassay for SF 86-327, a new antifungal agent. Kan, V.L., Henderson, D.K., Bennett, J.E. Antimicrob. Agents Chemother. (1986)
- DNA-Cu(II) poly(amine) complex membrane as novel catalytic layer for highly sensitive amperometric determination of hydrogen peroxide. Gu, T., Hasebe, Y. Biosensors & bioelectronics. (2006)